Latest Press Releases

Health News Posted on Tuesday, March 19, 2024

Premium Press Releases »

OBI Pharma Announces Poster Presentations at the AACR 2024 Annual Meeting for OBI-992 and GlycOBI™ ADC platform

TAIPEI, Taiwan, March 18, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data for OBI-992, a potential best-in-class anti-TROP2 Antibody-Drug Conjugate (ADC). When evaluated against comparative TROP2 ADCs, ...

Read More

TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

CANTON, Mich. (March 14, 2024) - TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ...

Read More

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third of respondents are now actively tracking their sleep patterns, ...

Read More

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm

Relation Therap eutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm London, March 2024 – Relation Therapeutics, a biotechnology company at the forefront of leveraging computational ...

Read More

Press Releases »

Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System

SUNNYVALE, Calif. , March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of its ...

Read More

Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

SHENZHEN, China , March 18, 2024 /PRNewswire/ -- On March 18 2024, Shenzhen chipscreen biosciences Co., Ltd. (hereinafter referred to as "chipscreen biosciences", stock code: 688321. SH) announced that the Phase II clinical trial ...

Read More

TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

CANTON, Mich. (March 14, 2024) - TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ...

Read More

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis

TEL AVIV, Israel , March 15, 2024 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases announced today the grant of a ...

Read More

How Nature's Body Boosts Immunity

The Australian Health and Wellness Brand Offers Natural Preventative Solutions to Stay Healthy This Winter FORT LAUDERDALE, Fla. , March 15, 2024 /PRNewswire/ -- The winter is a season filled with germs, viruses, and bacteria — a reality ...

Read More

Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates

ZHUHAI, China , March 15, 2024 /PRNewswire/ -- On March 14, 2024 , Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology and inflammatory diseases, and Hansoh ...

Read More

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

TAMPERE, Finland , March 14, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation for its RemeOs™ Spinal Interbody Cage implant from the US Food and Drug ...

Read More

Unlocking Beauty: Revolutionary Study by Renowned New York City Facial Surgeon Reveals Game-Changing Advances in Rhinoplasty

NEW YORK , March 14, 2024 /PRNewswire/ -- In a collaborative effort, Double Board Certified New York Facial Plastic Surgeon, Sam Rizk , MD, FACS , teams up with esteemed colleague Double Board Certified Chicago Facial Plastic Surgeon ...

Read More

myTomorrows Partners with The ALS Association to Support ALS Patients in Accessing Clinical Trials

Partnership with leading US-based ALS patient advocacy group furthers myTomorrows' mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options NEW YORK , March 14, 2024 /PRNewswire/ ...

Read More

Biotech's Role in Addressing the Pancreatic Cancer Emergency

FN Media Group Presents USA News Group News Commentary VANCOUVER, BC , March 14, 2024 /PRNewswire/ -- USA News Group - Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate ...

Read More

Ready for Launch: Coast Smokes and Willie's Remedy Launch Eco-Friendly CBD Hemp Smokes and Vapes

Introducing a cleaner, greener way to enjoy hemp smokeables: Biodegradable hemp filters and rechargeable vape batteries DALLAS , March 14, 2024 /PRNewswire-PRWeb/ -- Coast Smokes collaborates with Willie Nelson's legendary hemp brand, ...

Read More

Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis

Phase 1 Study Led by World-Renowned Expert Prof. Felice Petraglia to Evaluate Gynica's Non-Hormonal, Intra-Vaginal Drug Candidates In perfect timing with Endometriosis Awareness Month, the announcement of the study is one step forward for ...

Read More

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology

Co-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc. with participation from existing investors   Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden Lead program is AT-108, a first-in-class, off-the-shelf ...

Read More

Study shows improved hand function using Carbonhand

https://news.cision.com/bioservo-ab/i/table-1-measures-on-difficulty-in-chosen-activities,c3278007 Table 1 Measures on difficulty in chosen activities https://news.cision.com/bioservo-ab/i/gcom-2024-presentation,c3278171 ...

Read More

Circadia Health, Cleveland Clinic Research Collaboration Shows Predictive Power of Continuous Respiratory Monitoring in Prediction of Clinical Deterioration in COVID-19

The study, conducted in collaboration with the Cleveland Clinic, demonstrates Circadia Health's C100 system's ability to offer continuous, contactless respiratory monitoring, predicting clinical deterioration 24 hours in advance and enhancing ...

Read More

Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

KANSAS CITY, Mo. and WILMINGTON, Del. , March 13, 2024 /PRNewswire/ -- Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and  Geneyx  Inc. are pleased to announce a collaboration aimed at advancing ...

Read More

NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

Blinded Safety Review Completed for the First 6 Months of the Phase 2a Clinical Trial Conduct; Recommending Trial Continue Without Modification Full Data Readout Expected in the Second Half of 2024 CAMBRIDGE, Mass. , March 13, 2024 ...

Read More

Biocomposites announces approval of STIMULAN in Brazil as an antibiotic carrier for treating bacterial infection

STIMULAN®, when mixed with antibiotics, can be used for the treatment of bacterial infection STIMULAN® will be distributed exclusively by Bone Surgical in Brazil KEELE, England , March 13, 2024 /PRNewswire/ -- Biocomposites, an ...

Read More

Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI , March 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of three preclinical studies as poster presentation at the AACR ...

Read More

Creating a Better Environment for Remote Drug Testing Results

eRAMx Safeguards Drug Test Integrity with Features for Observation Quality INDIANAPOLIS , March 12, 2024 /PRNewswire/ -- Innovations in remote drug testing technology are allowing observers to actively improve a testing environment, ...

Read More

Lamassu Awarded NIH Grant For Breakthrough Cancer Treatment

Promising New Therapy for Sarcomas Could Reduce Reliance on Surgery, Chemotherapy and other Invasive and Toxic Treatments CLEVELAND , March 12, 2024 /PRNewswire/ -- Lamassu Bio Inc., a cutting-edge biotech company dedicated to ...

Read More

NeuroGenesis Reports Positive Results from Phase 2 Extension Study in Progressive Multiple Sclerosis Treated with NG-01 Cell Therapy

 Data presented by the MS team at Hadassah Medical Center, Jerusalem , led by Prof. Dimitrios Karussis, in the Americas Committee for Treatment and Research in Multiple Sclerosis Forum reveal consistent reductions in serum levels of both NfL ...

Read More

Oral Health Providers can now sign up to participate in the Canadian Dental Care Plan

OTTAWA, ON , March 11, 2024 /CNW/ - Starting today, oral health providers can confirm their participation in the CDCP through the Sun Life portal . In choosing to participate in the CDCP, oral health care providers are playing an important ...

Read More

Florida Selects DiaCarta's cfDNA Test (RadTox™) for Statewide Use to Detect Early Response of Cancer Treatment

PLEASANTON, Calif. , March 11, 2024 /PRNewswire/ -- DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly announced that Florida Health Department selected "using plasma ...

Read More

AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer

The Canadian venture capital fund CTI Life Sciences Fund III, Inveready and the EIC Fund from the European Commission close a round with the additional participation of CDTI Innvierte, FiTalent, family offices as well as founders.  BARCELONA, ...

Read More

RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024

YANTAI, China , March 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an interim analysis of the evaluation of the ...

Read More

Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting

HANGZHOU and SHAOXING, China , March 10, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the poster presentation of Phase II study final results of ASC40, a first-in-class fatty acid synthase (FASN) ...

Read More

OrthoVentions Invests in Motio[OV] to Develop 3D Printed Implant and Instruments to Treat Joint Arthritis of the Big Toe

ATLANTA , March 8, 2024 /PRNewswire/ -- OrthoVentions LLC today announced its investment in Motio OV , an early-stage company created in partnership with the Hospital for Special Surgery (HSS). Motio OV is developing a novel 3D printed ...

Read More

Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

CAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...

Read More

AMERICAN ACADEMY OF DERMATOLOGY: MILITARY MEMBERS MORE AT RISK FOR MELANOMA

Board-certified dermatologist discusses occupational risks of skin cancer for those who serve  SAN DIEGO , March 8, 2024 /PRNewswire/ -- U.S. veterans are at a higher risk of developing melanoma, one of the deadliest forms of skin ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.